Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 24;47(5):298.
doi: 10.3390/cimb47050298.

Endometriosis and Adenomyosis: From Pathogenesis to Follow-Up

Affiliations
Review

Endometriosis and Adenomyosis: From Pathogenesis to Follow-Up

Francesco Giuseppe Martire et al. Curr Issues Mol Biol. .

Abstract

Endometriosis and adenomyosis are chronic, hormone-dependent disorders. Estrogens, in particular, play a pivotal role in the pathophysiology of these conditions. Understanding the disease mechanisms, including local hyperestrogenism and reduced progesterone sensitivity, is crucial for effective management. Early diagnosis is essential for appropriate therapeutic intervention, with medical hormonal treatment being the first-line approach. It is important to monitor patients over time and tailor hormone therapy to individual needs in order to optimize treatment adherence. Medical therapy not only enhances patients' quality of life but also appears to slow disease progression in terms of both extent and severity. This narrative review aims to explore all aspects of endometriosis and adenomyosis, from pathogenesis to clinical symptoms, with particular emphasis on the role of hormones and the use of medical therapies.

Keywords: adenomyosis; endometriosis; management; pathogenesis; symptoms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Pathogenesis theories: (A) common pathogenetic factors of endometriosis and adenomyosis; (B) specific pathogenetic factors of adenomyosis; (C) specific pathogenetic factors of endometriosis.
Figure 2
Figure 2
Diagram of management.

References

    1. Becker C.M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L., King K., Kvaskoff M., Nap A., Petersen K., et al. ESHRE guideline: Endometriosis. Hum. Reprod. Open. 2022;2022:hoac009. doi: 10.1093/hropen/hoac009. - DOI - PMC - PubMed
    1. Martire F.G., d’Abate C., Schettini G., Cimino G., Ginetti A., Colombi I., Cannoni A., Centini G., Zupi E., Lazzeri L. Adenomyosis and Adolescence: A Challenging Diagnosis and Complex Management. Diagnostics. 2024;14:2344. doi: 10.3390/diagnostics14212344. - DOI - PMC - PubMed
    1. Laganà A.S., Garzon S., Götte M., Viganò P., Franchi M., Ghezzi F., Martin D.C. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights. Int. J. Mol. Sci. 2019;20:5615. doi: 10.3390/ijms20225615. - DOI - PMC - PubMed
    1. Martire F.G., Giorgi M., D’abate C., Colombi I., Ginetti A., Cannoni A., Fedele F., Exacoustos C., Centini G., Zupi E., et al. Deep Infiltrating Endometriosis in Adolescence: Early Diagnosis and Possible Prevention of Disease Progression. J. Clin. Med. 2024;13:550. doi: 10.3390/jcm13020550. - DOI - PMC - PubMed
    1. Moradi M., Parker M., Sneddon A., Lopez V., Ellwood D. Impact ofendometriosis on women’s lives: A qualitative study. BMC Women’s Health. 2014;14:123. doi: 10.1186/1472-6874-14-123. - DOI - PMC - PubMed

LinkOut - more resources